Abstract

BackgroundThe lack of effective treatments for Alzheimer’s disease (AD) reflects an incomplete understanding of disease mechanisms. Alterations in proteins involved in mitochondrial dynamics, an essential process for mitochondrial integrity and function, have been reported in AD brains. Impaired mitochondrial dynamics causes mitochondrial dysfunction and has been associated with cognitive impairment in AD. Here, we investigated a possible link between pro-inflammatory interleukin-1 (IL-1), mitochondrial dysfunction, and cognitive impairment in AD models.MethodsWe exposed primary hippocampal cell cultures to amyloid-β oligomers (AβOs) and carried out AβO infusions into the lateral cerebral ventricle of cynomolgus macaques to assess the impact of AβOs on proteins that regulate mitochondrial dynamics. Where indicated, primary cultures were pre-treated with mitochondrial division inhibitor 1 (mdivi-1), or with anakinra, a recombinant interleukin-1 receptor (IL-1R) antagonist used in the treatment of rheumatoid arthritis. Cognitive impairment was investigated in C57BL/6 mice that received an intracerebroventricular (i.c.v.) infusion of AβOs in the presence or absence of mdivi-1. To assess the role of interleukin-1 beta (IL-1β) in AβO-induced alterations in mitochondrial proteins and memory impairment, interleukin receptor-1 knockout (Il1r1−/−) mice received an i.c.v. infusion of AβOs.ResultsWe report that anakinra prevented AβO-induced alteration in mitochondrial dynamics proteins in primary hippocampal cultures. Altered levels of proteins involved in mitochondrial fusion and fission were observed in the brains of cynomolgus macaques that received i.c.v. infusions of AβOs. The mitochondrial fission inhibitor, mdivi-1, alleviated synapse loss and cognitive impairment induced by AβOs in mice. In addition, AβOs failed to cause alterations in expression of mitochondrial dynamics proteins or memory impairment in Il1r1−/− mice.ConclusionThese findings indicate that IL-1β mediates the impact of AβOs on proteins involved in mitochondrial dynamics and that strategies aimed to prevent pathological alterations in those proteins may counteract synapse loss and cognitive impairment in AD.

Highlights

  • Alzheimer’s disease (AD) is characterized by progressive memory loss and brain dysfunction that results from deterioration of synapses and brain cells [1, 2]

  • Batista et al Journal of Neuroinflammation (2021) 18:54 (Continued from previous page). These findings indicate that Interleukin-1 beta (IL-1β) mediates the impact of Amyloid-β oligomer (AβO) on proteins involved in mitochondrial dynamics and that strategies aimed to prevent pathological alterations in those proteins may counteract synapse loss and cognitive impairment in AD

  • An IL-1 receptor antagonist, attenuates the impact of AβOs on mitochondrial membrane potential and fusion/fission proteins IL-1β has been found to be elevated in human AD brains [30,31,32] and in the brains of AβO-infused mice [34]

Read more

Summary

Introduction

Alzheimer’s disease (AD) is characterized by progressive memory loss and brain dysfunction that results from deterioration of synapses and brain cells [1, 2]. Oxidative stress occurs when mitochondrial function is impaired [3,4,5]. Mitochondrial function requires proper mitochondrial dynamics, which comprises continuous and balanced processes of mitochondrial fission, fusion, and transport [6]. Mitochondrial fusion is controlled by two outer-membranelocalized proteins, mitofusins 1 and 2 (MFN-1 and MFN-2), and one inner-membrane-localized protein, optic atrophy 1 (OPA-1) [6]. Mitochondrial fission, on the other hand, is mainly controlled by dynamin-related protein 1 (Drp1), which is predominantly localized in the cytosol and is recruited to the mitochondrial outer membrane to drive this process [6]. Alterations in proteins involved in mitochondrial dynamics, an essential process for mitochondrial integrity and function, have been reported in AD brains. We investigated a possible link between pro-inflammatory interleukin-1 (IL-1), mitochondrial dysfunction, and cognitive impairment in AD models

Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call